FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
Published on March 11, 2026 at 05:33PM by Drugs.com - Daily MedNews
WEDNESDAY, March 11, 2026 — The U.S. Food and Drug Administration (FDA) has approved a generic drug for a very rare brain disorder, but said it should not be considered a treatment for autism. On Tuesday, the agency cleared leucovorin for...
Read the original article here: https://www.drugs.com/news/fda-approves-leucovorin-rare-brain-disorder-not-autism-129122.html